TANI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 9.918
AS - Asia 4.865
EU - Europa 3.374
SA - Sud America 942
AF - Africa 266
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.379
Nazione #
US - Stati Uniti d'America 9.629
SG - Singapore 1.550
CN - Cina 1.252
IT - Italia 984
HK - Hong Kong 833
BR - Brasile 758
SE - Svezia 698
VN - Vietnam 517
DE - Germania 346
BG - Bulgaria 317
GB - Regno Unito 209
CA - Canada 208
TR - Turchia 196
FR - Francia 189
FI - Finlandia 173
RU - Federazione Russa 148
IN - India 138
CI - Costa d'Avorio 93
JP - Giappone 76
AR - Argentina 62
UA - Ucraina 57
AT - Austria 47
SN - Senegal 45
MX - Messico 44
BD - Bangladesh 42
IQ - Iraq 35
ES - Italia 33
NG - Nigeria 33
ID - Indonesia 30
PL - Polonia 30
NL - Olanda 29
BE - Belgio 27
ZA - Sudafrica 27
PK - Pakistan 26
KR - Corea 25
CO - Colombia 24
VE - Venezuela 24
EC - Ecuador 21
MA - Marocco 21
SA - Arabia Saudita 21
CH - Svizzera 18
PY - Paraguay 17
CL - Cile 15
MY - Malesia 15
EG - Egitto 13
UZ - Uzbekistan 13
PE - Perù 12
PT - Portogallo 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
JO - Giordania 9
LT - Lituania 9
PH - Filippine 9
AL - Albania 8
IL - Israele 8
AU - Australia 7
OM - Oman 7
RS - Serbia 7
DO - Repubblica Dominicana 6
IR - Iran 6
KZ - Kazakistan 6
RO - Romania 6
TN - Tunisia 6
UY - Uruguay 6
CR - Costa Rica 5
IE - Irlanda 5
JM - Giamaica 5
AZ - Azerbaigian 4
BJ - Benin 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
EU - Europa 4
LB - Libano 4
NI - Nicaragua 4
NP - Nepal 4
PA - Panama 4
PS - Palestinian Territory 4
TW - Taiwan 4
BH - Bahrain 3
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
MD - Moldavia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AO - Angola 1
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
Totale 19.355
Città #
Ashburn 1.019
Woodbridge 883
Singapore 833
Hong Kong 817
Fairfield 767
Santa Clara 620
Houston 583
Chandler 552
Ann Arbor 547
San Jose 477
Dallas 467
Seattle 333
Shanghai 331
Sofia 315
New York 283
Beijing 282
Milan 260
Cambridge 250
Wilmington 230
Boardman 179
Los Angeles 154
Ottawa 154
Princeton 132
Ho Chi Minh City 131
Lawrence 125
Lauterbourg 119
Medford 117
Hanoi 109
Munich 106
Abidjan 93
Izmir 88
Des Moines 87
London 86
Serra 85
Florence 81
Istanbul 73
Tokyo 72
Nanjing 71
Council Bluffs 68
Boulder 64
Redondo Beach 64
Hefei 57
Bremen 56
Jacksonville 56
Frankfurt am Main 55
Dearborn 53
Dong Ket 52
Helsinki 50
São Paulo 50
San Diego 49
Dakar 45
Rome 44
Turku 44
Buffalo 39
Falls Church 37
Nanchang 36
Ogden 36
Pune 33
Vienna 33
Redwood City 32
Lagos 28
Lancaster 27
Brussels 26
Pisa 24
Columbus 22
Seoul 22
Chicago 20
Fuzhou 20
Nuremberg 20
Düsseldorf 19
Hebei 19
Livorno 19
Warsaw 19
Belo Horizonte 18
Changsha 18
Montreal 18
Baghdad 17
Brooklyn 17
Atlanta 16
Da Nang 16
Norwalk 16
Rio de Janeiro 16
Tianjin 16
Bologna 15
Curitiba 14
Denver 14
Shenyang 14
The Dalles 14
Thái Bình 14
Toronto 14
Brasília 13
Chennai 13
Haiphong 13
Jiaxing 13
Johannesburg 13
Kunming 13
Orem 13
Paris 12
Porto Alegre 12
Quanzhou 12
Totale 13.643
Nome #
Leukopenia, lymphopenia, andneutropenia in systemic lupus erythematosus: Prevalence and clinical impact--A systematic literature review 242
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus. 236
Depression and systemic lupus erythematosus: a systematic review 227
Insomnia symptoms, perceived stress and coping strategies in patients with systemic lupus erythematosus 211
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 199
Antipolymer antibody in Italian fibromyalgic patients 198
Bilateral hemorrhagic fetal ovarian cyst: a case report 197
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 186
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 180
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. 180
Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus 179
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 179
null 179
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. 178
ARTHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN IMAGING POINT OF VIEW 175
One year in review 2017: systemic lupus erythematosus 175
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 173
The role of imaging in the evaluation of joint involvement in 102 consecutive patients with systemic lupus erythematosus 172
Undifferentiated connective tissue diseases (UCTD) 170
Epidemiology and Management of Neuropsychiatric Disorders in Behçet's Syndrome. 170
Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. 170
Vascular reactivity in patients with undifferentiated connective tissue diseases 166
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 165
Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases 163
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases 162
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 161
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome. 160
Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus 159
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 157
Prognostic value of flow mediated dilation in patients with systemic lupus erythematosus: A pilot prospective cohort study. 156
Undifferentiated connective tissue diseases (UCTD): Simplified systemic autoimmune diseases 154
Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology 153
Poor sleep quality in systemic lupus erythematosus: does it depend on depressive symptoms 153
Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis 153
UCTD and SLE patients show increased levels of oxidative and DNA damage together with an altered kinetics of DSB repair 153
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 152
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. 151
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study 147
Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients 146
[Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide] 146
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies 145
Outcome of pregnancy in Italian patients with primary Sjögren syndrome 144
The diagnosis and classification of undifferentiated connective tissue diseases. 144
COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases 142
The economic impact of gout: a systematic literature review. 142
When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease 141
Systemic lupus erythematosus: state of the art on clinical practice guidelines 141
One year in review: the pathogenesis of rheumatoid arthritis 141
Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centres 140
Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation? 140
Analysis of the evolution of UCTD to defined CTD after a long-term follow-up. 139
Aderenza allo screening per il cancro della cervice uterina in una coorte italiana di donne affette da LES [Adherence to cervical cancer screening in an Italian SLE cohort] 139
Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience 139
Systemic Vasculitis and Pregnancy: Maternal and Neonatal Outcome of 20 Prospectively Followed Pregnancies 138
The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice 138
A case of undifferentiated connective tissue disease: is it a distinct clinical entity? 137
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 136
Evoluzione verso connettiviti definite in una popolazione di pazienti affetti da “early undifferentiated connective tissue disease” [Analysis of the evolution to defined connective tissue diseases of patients with early undifferentiated connective tissue diseases (UCTD)] 134
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry). 133
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the “Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group” 131
successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. 131
Defining undifferentiated connective tissue diseases: a challenge for rheumatologists 130
Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice 130
Pregnancy and undifferentiated connective tissue disease: outcome and risk of flare in 100 pregnancies 129
Comparison of real-time PCR and nested PCR for the detection of Y chromosome sequences in the peripheral blood mononuclear cells of patients with systemic sclerosis 128
Undifferentiated CTD: a wide spectrum of autoimmune diseases 128
Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare 128
Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream. 127
Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD. 127
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 127
Human papillomavirus infection and cervical lesions in rheumatic diseases: a systematic review 126
Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus 126
Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort 124
Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology? 122
What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis 121
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 121
Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus 121
Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis? 120
Post-traumatic stress disorder and post-traumatic stress symptoms in patients with systemic autoimmune diseases during the COVID-19 pandemic. 119
Cell-free DNA in the plasma of patients with systemic sclerosis 119
Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus. 118
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products 117
Translation, cultural adaptation and validation of the Italian version of the Brief Index of Lupus Damage: the BILDit 117
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies 116
Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE - 18 months later 114
Mortality in giant cell arteritis: analysis of a monocentric cohort of biopsy-proven patients. 114
Vascular reactivity in patients with undifferentiated connective tissue diseases 114
Anti-C1q antibodies in pregnant patients with systemic lupus eruthematosus 114
Health information technologies in systemic lupus erythematosus: focus on patient assessment 114
"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 114
Which extra-renal flare is 'difficult to treat' in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches. 113
Imaging of joints in systemic lupus erythematosus 113
Glucocorticoids in systemic lupus erythematosus. 111
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies 111
Pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Practical messages from the EULAR guidelines. 111
Gender differences in SLE: report from a cohort of 417 Caucasian patients. 110
A case of undifferentiated connective tissue disease: is it a distinct clinical entity? 109
null 107
Long-Term Outcome of Idiopathic Uveitis: A Prospective Cohort Study 107
Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients 106
Totale 14.471
Categoria #
all - tutte 58.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.402 41 70 6 112 273 240 29 58 56 50 80 387
2022/20231.873 245 295 121 176 197 223 28 142 301 17 108 20
2023/20241.305 93 116 132 81 178 268 128 30 27 12 85 155
2024/20254.449 22 164 97 246 417 518 425 203 406 592 482 877
2025/20265.080 291 569 638 614 592 446 745 250 228 398 211 98
2026/202731 31 0 0 0 0 0 0 0 0 0 0 0
Totale 19.755